Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Barclays Plc    BARC   GB0031348658

BARCLAYS PLC

(BARC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
151.32(c) 146.86(c) 146.32(c) 144.8(c) 143.06(c) Last
18 152 378 39 716 396 33 762 455 20 645 046 51 874 816 Volume
+1.69% -2.95% -0.37% -1.04% -1.20% Change
More quotes
Financials
Sales 2020 21 590 M 29 540 M 29 540 M
Net income 2020 1 148 M 1 570 M 1 570 M
Net Debt 2020 - - -
P/E ratio 2020 21,4x
Yield 2020 1,79%
Sales 2021 20 666 M 28 275 M 28 275 M
Net income 2021 2 241 M 3 067 M 3 067 M
Net Debt 2021 - - -
P/E ratio 2021 10,5x
Yield 2021 3,82%
Capitalization 24 833 M 33 930 M 33 976 M
Capi. / Sales 2020 1,15x
Capi. / Sales 2021 1,20x
Nbr of Employees 80 800
Free-Float 99,6%
More Financials
Company
Barclays Plc is one of Britain's leading banking groups. The activity is organized around three sectors: - commercial banking: at the end of 2019, owned 963 branches worldwide; - financing, investment, and market banking: specialized financing (acquisitions, projects, etc.), portfolio management, transactions on the stock, interest, exchange, and raw material markets, stock trading, merger-acquisition consulting,... 
Sector
Banks
Calendar
02/18Earnings Release
More about the company
Notations Surperformance© of Barclays Plc
Trading Rating : Investor Rating :
More Ratings
All news about BARCLAYS PLC
01/22SECTOR UPDATE : Health Care Stocks Sputter Late, Drift Back Near Friday Starting..
MT
01/22ECB Considers Ending Private Calls to Banks, Investors After Policy Meetings
DJ
01/22SECTOR UPDATE : Slim Advance for Health Care Stocks Amid Biotech Rebound
MT
01/22SPRINGWORKS THERAPEUTICS : Barclays Adjusts Price Target on SpringWorks Therapeu..
MT
01/22ESSENTIAL UTILITIES : Barclays Adjusts Price Target on Essential Utilities Inc t..
MT
01/22AMERICAN WATER WORKS : Barclays Adjusts Price Target on American Water Works to ..
MT
01/22SENSATA TECHNOLOGIES : Barclays Adjusts Sensata Technologies' Price Target to $6..
MT
01/22TRAVELERS : Barclays Adjusts Price Target on The Travelers Companies to $155 fro..
MT
01/22AMERICAN EAGLE OUTFITTERS : Barclays Adjusts Price Target on American Eagle Outf..
MT
01/22INTEL : Barclays Raises Intel's Price Target to $53 From $50, Maintains Underwei..
MT
01/22BAYER AG : Barclays reiterates its Neutral rating
MD
01/22MERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/22MORPHOSYS : Barclays reiterates its Neutral rating
MD
01/22ROCHE HOLDINGS AG : Barclays reiterates its Buy rating
MD
01/22ASTRAZENECA : Barclays reaffirms its Buy rating
MD
More news
News in other languages on BARCLAYS PLC
01/22BOURSE ZURICH : en ordre dispersé pour la dernière séance de la semaine
01/22AKTIE IM FOKUS : Starkes Werbegeschäft lässt ProSiebenSat.1-Anleger jubeln
01/22Bourse Zurich: "la fête est finie" à l'approche du week-end
01/22Bourse Zurich: ouverture en repli, juste en dessous des 10'900 points
01/22Bourse Zurich: recul attendu à l'ouverture, la pandémie inquiète
More news
Analyst Recommendations on BARCLAYS PLC
More recommendations
Chart BARCLAYS PLC
Duration : Period :
Barclays Plc Technical Analysis Chart | BARC | GB0031348658 | MarketScreener
Technical analysis trends BARCLAYS PLC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 163,28 GBX
Last Close Price 143,06 GBX
Spread / Highest target 64,3%
Spread / Average Target 14,1%
Spread / Lowest Target -48,9%
EPS Revisions
Managers and Directors
NameTitle
James Edward Staley Group Chief Executive Officer & Director
Nigel Paul Higgins Group Chairman
Mark Ashton Rigby Group Chief Operating Officer
Tushar Morzaria Group Finance Director & Executive Director
Timothy James Breedon Independent Non-Executive Director
Sector and Competitors